Macrophages promote endothelial-to-mesenchymal transition via MT1-MMP/TGFβ1 after myocardial infarction.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33063665.
- Also identified by DOI 10.7554/eLife.57920 and PMC identifier 7609061.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Macrophages (Mφs) produce factors that participate in cardiac repair and remodeling after myocardial infarction (MI); however, how these factors crosstalk with other cell types mediating repair is not fully understood. Here we demonstrated that cardiac Mφs increased the expression of <i>Mmp14</i> (MT1-MMP) 7 days post-MI. We selectively inactivated the <i>Mmp14</i> gene in Mφs using a genetic strategy (<i>Mmp14</i><sup>f/f</sup>:<i>Lyz2</i>-Cre). This conditional KO (MAC-Mmp14 KO) resulted in attenuated post-MI cardiac dysfunction, reduced fibrosis, and preserved cardiac capillary network. Mechanistically, we showed that MT1-MMP activates latent TGFβ1 in Mφs, leading to paracrine SMAD2-mediated signaling in endothelial cells (ECs) and endothelial-to-mesenchymal transition (EndMT). Post-MI MAC-Mmp14 KO hearts contained fewer cells undergoing EndMT than their wild-type counterparts, and <i>Mmp14</i>-deficient Mφs showed a reduced ability to induce EndMT in co-cultures with ECs. Our results indicate the contribution of EndMT to cardiac fibrosis and adverse remodeling post-MI and identify Mφ MT1-MMP as a key regulator of this process.
Medical subject headings
- Endothelium, Vascular
- Epithelial-Mesenchymal Transition
- Macrophages
- Matrix Metalloproteinase 14
- Myocardial Infarction
- Transforming Growth Factor beta1